BioInvent International AB (BINV) — Cash Flow Reinvestment Rate

Latest as of June 2025: 1.93x

BioInvent International AB (BINV) has a Cash Flow Reinvestment Rate of 1.93x as of June 2025, reinvesting Skr128.56 Million (capex Skr1.38 Million plus investments Skr-127.18 Million) from operating cash flow of Skr66.78 Million. See BioInvent International AB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.93x
(Capex + Investments) / Operating CF

Total Reinvested

Skr128.56 Million
Capex + Investments

Operating Cash Flow

Skr66.78 Million
SEK

Capital Expenditures

Skr1.38 Million
SEK

BioInvent International AB Cash Flow Reinvestment Rate (2007–2008)

Historical reinvestment intensity for BioInvent International AB across 2 annual periods. For the full cash flow conversion analysis, see BINV cash flow metrics.

Annual Cash Flow Reinvestment Rate for BioInvent International AB (2007–2008)

Year-by-year capital reinvestment analysis for BioInvent International AB. See BINV free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2008 0.31x Skr13.64 Million Skr43.73 Million Skr13.64 Million ▲ +0.8%
2007 0.31x Skr3.91 Million Skr12.63 Million Skr3.91 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow